Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2003
03/05/2003EP1287138A1 Novel g-protein coupled receptor
03/05/2003EP1287136A1 Modified chemokine receptor ccr-3 and assay
03/05/2003EP1287134A2 The human voltage-gated sodium channel beta-1a subunit and methods of use
03/05/2003EP1287132A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/05/2003EP1287131A2 Regulator of g protein signalling (rgs8)
03/05/2003EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
03/05/2003EP1287123A2 Subtilisin variants
03/05/2003EP1287120A2 Human circulating dendritic cell compositions and methods
03/05/2003EP1287119A2 Mammalian gamete and embryo culture media supplement and method of using same
03/05/2003EP1287118A2 Method for producing a recipient-specific tissue transplant or tissue implant
03/05/2003EP1287117A1 Method for production and cryopreservation of bovine embryos developed in vitro and frozen straw for direct transferring same
03/05/2003EP1287116A2 Neural progenitor cell populations
03/05/2003EP1287115A2 Retinal pigment epithelial cell lines with extended life-span and their applications
03/05/2003EP1287035A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/05/2003EP1287034A2 Derivatives of breast cancer antigen her-2 for therapeutical use
03/05/2003EP1287032A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
03/05/2003EP1287029A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287028A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287025A1 Sheep lice, bovicola ovis, allergen treatment
03/05/2003EP1287024A2 Virulence genes, proteins, and their use
03/05/2003EP1287023A1 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
03/05/2003EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents
03/05/2003EP1287015A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
03/05/2003EP1286708A1 Method for producing a bio-artificial transplant
03/05/2003EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
03/05/2003EP1286689A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
03/05/2003EP1286684A2 Cxcr4 antagonist treatment of hematopoietic cells
03/05/2003EP1286682A1 Methods and compositions for inhibiting immunoglobulin-mediated--reperfusion injury
03/05/2003EP0973874B1 Enzyme assay for mutant firefly luciferase
03/05/2003EP0877795A4 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
03/05/2003EP0822824A4 Method of pretreating viable tissue or cells to be contained within a semipermeable vessel
03/05/2003EP0791009A4 Modified neuropeptide y receptors
03/05/2003EP0728143B1 Oncoprotein protein kinase
03/05/2003EP0554352B1 A method for transplanting cells into the brain and therapeutic uses therefor
03/05/2003CN1401004A Alteration of growth and adaptation under hypoxic conditions
03/05/2003CN1401003A Gene Sp17 inhibiting lesion formation in plant and utilization thereof
03/05/2003CN1401001A 5HT3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof
03/05/2003CN1400910A Factor VII or VIIa like molecules
03/05/2003CN1400906A Treatment of congestive heart failure by pretreated autologous blood
03/05/2003CN1400307A Method for producing chymopapain by utilizing papaya cell culture
03/05/2003CN1400306A Method of providing substrate with homogenously distributed extracellular matter
03/05/2003CN1400222A Monoclonal antibody resisting human small cell lung carcinoma and its application
03/04/2003WO2002020614A2 Endoglin-specific polypeptide, production and use thereof
03/04/2003US6528705 Method for improving productivity of higher plants
03/04/2003US6528637 Fatty acid synthase mRNA binding protein
03/04/2003US6528634 Aiolos gene
03/04/2003US6528626 Viral library for use in the diagnosis and treatment of viral diseases
03/04/2003US6528623 Antibodies that specifically bind ACT-4-L-h-1 ligand
03/04/2003US6528482 Receptor activator of NF-κB
03/04/2003US6528314 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made
03/04/2003US6528313 Production of transgenic animals; targeted replacement of an endogenous gene; genetic trait expression
03/04/2003US6528309 Vacuum-mediated desiccation protection of cells
03/04/2003US6528308 Type-1 Human Immunodeficiency Virus (HIV-1); Permanently established lymphocyte cell lines that produce an antiviral compound; CD8+ suppressor molecule
03/04/2003US6528307 Stable cloned T-lymphocyte cell line; use therapy, bioassay, drug screening, anticancer agent
03/04/2003US6528306 Engraftable human neural stem cells
03/04/2003US6528305 Method of producing infectious reovirus
03/04/2003US6528304 Eukaryotic cells expressing at their surface at least an HLA-G isoform and their applications
03/04/2003US6528303 Neuropeptide Y-Y5 receptor
03/04/2003US6528300 Glutaryl cephalosporin amidase from Pseudomonas diminuta BS-203
03/04/2003US6528297 Human lysozyme gene, its encoded polypeptide and the method for preparing them
03/04/2003US6528294 To effect protein phosphorylation; for use in diagnosis and therapy
03/04/2003US6528286 In which the sialic acid content is increased by addition of copper ion to a serum-free medium; can lengthen protein bioavailability and serum half-life
03/04/2003US6528284 S-Region Transfer Activity-70 (SRTA-70); can be used as therapeutic agents in immune response modulation
03/04/2003US6528283 Members of the D52 Gene family
03/04/2003US6528281 DNA encoding human interleukin-11 receptor
03/04/2003US6528276 Fusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activity
03/04/2003US6528271 Drug screening
03/04/2003US6528245 Bone marrow cells as a source of neurons for brain and spinal cord repair
03/04/2003US6528064 Recombinant trytophan mutants of influenza
03/04/2003US6528060 Therapeutic compounds
03/04/2003US6528055 Polypeptide for use in the diagnosis, treatment and prevention of infections, immune response defects and autoimmune diseases
03/04/2003US6528054 Comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast
03/04/2003US6528052 A method for in vivo, ex vivo or in vitro repair and regeneration of degenerated, diseased or injured articular cartilage or for de novo production of cartilage, collagen, ligaments, tendons or bone, said method comprising a step of
03/04/2003US6528038 An immune response directed against Porphyromonas gingivalis. The composition includes a suitable adjuvant and/or acceptable carrier and one substantially purified P. gingivalis immunogen. The immunogen is selected from the group consisting
03/04/2003CA2421202A1 Endoglin-specific polypeptide, production and use thereof
02/2003
02/28/2003CA2400531A1 Human nhe2
02/27/2003WO2003016917A2 Sodium channel regulators and modulators
02/27/2003WO2003016916A1 Identification and isolation of somatic stem cells and uses thereof
02/27/2003WO2003016867A2 Method and quantification assay for determining c-kit/scf/pakt status
02/27/2003WO2003016860A2 Systems and methods for screening pharmaceutical chemicals
02/27/2003WO2003016549A2 Nucleic-acid associated proteins
02/27/2003WO2003016541A1 Premeabilisation of cells
02/27/2003WO2003016537A2 Method for repairing a mutant rna from a dna with genetic defects and for the programmed death of tumour cells by rna trans-splicing as well as a method for identifying naturally trans-spliced cellular rna
02/27/2003WO2003016535A2 Novel amylases and uses thereof
02/27/2003WO2003016533A1 GENE qSH-1 INDUCING PLANT THRESHABILITY AND UTILIZATION OF THE SAME
02/27/2003WO2003016522A2 Methods and compounds for the targeting of protein to exosomes
02/27/2003WO2003016516A2 Kinase crystal structures and materials and methods for kinase activation
02/27/2003WO2003016513A1 Epstein-barr virus-negative nk cell line
02/27/2003WO2003016511A1 Method of extended culture for antigen-specific cytotoxic t lumphocytes
02/27/2003WO2003016510A1 New biopesticide using gene from erwinia pyrifoliaewt#3, novel pathogen that affects asian pear trees
02/27/2003WO2003016507A2 Generation of multipotent central nervous system stem cells
02/27/2003WO2003016506A2 Secreted proteins
02/27/2003WO2003016496A2 Zinc finger binding domains for cnn
02/27/2003WO2003016493A2 Transporters and ion channels
02/27/2003WO2003016491A2 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
02/27/2003WO2003016488A2 Cell separation system
02/27/2003WO2003016486A2 Bio-synthetic photostimulators and methods of use
02/27/2003WO2003016481A2 Novel human collagen proteins and polynucleotides encoding the same
02/27/2003WO2003016477A2 Insect or83b odorant receptor
02/27/2003WO2003016471A2 Periostin-based diagnostic assays
1 ... 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 ... 1827